Medincell, a clinical-stage pharmaceutical company in long-acting injectable therapies, today announced the expanded role of Dr Grace Kim, Chief Strategy Officer, U.S. Finance. Over the past two years, Kim has played has initial and decisive role in shaping the company’s U.S. capital growth strategy and advancing cross-border initiatives. As Medincell enters a pivotal growth phase, Kim will build on this foundation to lead and execute the next stages of the company’s U.S. capital growth st...